Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2022

Open Access 01-12-2022 | Pulmonary Edema | Research

Association of variants m.T16172C and m.T16519C in whole mtDNA sequences with high altitude pulmonary edema in Han Chinese lowlanders

Authors: Yan Wang, Xuewen Huang, Fujun Peng, Huiling Han, Yanan Gu, Xin Liu, Zhichun Feng

Published in: BMC Pulmonary Medicine | Issue 1/2022

Login to get access

Abstract

Background

High altitude pulmonary edema (HAPE) is a hypoxia-induced non-cardiogenic pulmonary edema that typically occurred in un-acclimatized lowlanders, which inevitably leads to life-threatening consequences. Apart from multiple factors involved, the genetic factors also play an important role in the pathogenesis of HAPE. So far, researchers have put more energy into the nuclear genome and HAPE, and ignored the relationship between the mitochondrion DNA (mtDNA) variants and HAPE susceptibility.

Methods

We recruited a total of 366 individuals including 181 HAPE patients and 185 non-HAPE populations through two times. The first time, 49 HAPE patients and 58 non-HAPE individuals were performed through whole mtDNA sequences to search the mutations and haplogroups. The second time, 132 HAPE patients and 127 non-HAPE subjects were collected to apply verifying these mutations and haplogroups of mtDNA with the routine PCR method.

Results

We analyzed and summarized the clinical characteristics and sequence data for the 49 HAPE patients and 58 non-HAPE individuals. We found that a series of routine blood indexes including systolic arterial blood pressure (SBP), heart rate (HR), white blood cell (WBC), and C-reactive protein (CRP) in the HAPE group presented higher and displayed significant differences compared with those in the non-HAPE group. Although the average numbers of variants in different region and group samples were not statistically significant (P > 0.05), the mutation densities of different regions in the internal group showed significant differences. Then we found two mutations (T16172C and T16519C) associated with the HAPE susceptibility, the T16172C mutation increased the risk of HAPE, and the T16519C mutation decreased the HAPE rating. Furthermore, the two mutations were demonstrated with 132 HAPE patients and 127 non-HAPE individuals. Unfortunately, all the haplogroups were not associated with the HAPE haplogroups.

Conclusions

We provided evidence of differences in mtDNA polymorphism frequencies between HAPE and non-HAPE Han Chinese. Genotypes of mtDNA 16172C and 16519C were correlated with HAPE susceptibility, indicating the role of the mitochondrial genome in the pathogenesis of HAPE.
Appendix
Available only for authorised users
Literature
2.
go back to reference Burtscher M, Mairer K, Wille M, Gatterer H, Ruedl G, Faulhaber M, Sumann G. Short-term exposure to hypoxia for work and leisure activities in health and disease: which level of hypoxia is safe? Sleep Breath. 2012;16(2):435–42.PubMedCrossRef Burtscher M, Mairer K, Wille M, Gatterer H, Ruedl G, Faulhaber M, Sumann G. Short-term exposure to hypoxia for work and leisure activities in health and disease: which level of hypoxia is safe? Sleep Breath. 2012;16(2):435–42.PubMedCrossRef
3.
go back to reference Jensen JD, Vincent AL: High altitude pulmonary edema (HAPE). In: StatPearls. edn. Treasure Island (FL); 2020. Jensen JD, Vincent AL: High altitude pulmonary edema (HAPE). In: StatPearls. edn. Treasure Island (FL); 2020.
4.
go back to reference Honigman B, Theis MK, Koziol-McLain J, Roach R, Yip R, Houston C, Moore LG, Pearce P. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 1993;118(8):587–92.PubMedCrossRef Honigman B, Theis MK, Koziol-McLain J, Roach R, Yip R, Houston C, Moore LG, Pearce P. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 1993;118(8):587–92.PubMedCrossRef
7.
go back to reference Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991;325(18):1284–9.PubMedCrossRef Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991;325(18):1284–9.PubMedCrossRef
8.
go back to reference Paralikar SJ. High altitude pulmonary edema-clinical features, pathophysiology, prevention and treatment. Indian J Occup Environ Med. 2012;16(2):59–62.PubMedPubMedCentralCrossRef Paralikar SJ. High altitude pulmonary edema-clinical features, pathophysiology, prevention and treatment. Indian J Occup Environ Med. 2012;16(2):59–62.PubMedPubMedCentralCrossRef
9.
go back to reference Dunham-Snary KJ, Wu D, Sykes EA, Thakrar A, Parlow LRG, Mewburn JD, Parlow JL, Archer SL. Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest. 2017;151(1):181–92.PubMedCrossRef Dunham-Snary KJ, Wu D, Sykes EA, Thakrar A, Parlow LRG, Mewburn JD, Parlow JL, Archer SL. Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest. 2017;151(1):181–92.PubMedCrossRef
10.
go back to reference Lumb AB, Slinger P. Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications. Anesthesiology. 2015;122(4):932–46.PubMedCrossRef Lumb AB, Slinger P. Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications. Anesthesiology. 2015;122(4):932–46.PubMedCrossRef
11.
go back to reference Qi Y, Niu W, Zhu T, Zhou W, Qiu C. Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol. 2008;23(2):143–52.PubMedCrossRef Qi Y, Niu W, Zhu T, Zhou W, Qiu C. Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol. 2008;23(2):143–52.PubMedCrossRef
12.
go back to reference Soree P, Gupta RK, Singh K, Desiraju K, Agrawal A, Vats P, Bharadwaj A, Baburaj TP, Chaudhary P, Singh VK, et al. Raised HIF1alpha during normoxia in high altitude pulmonary edema susceptible non-mountaineers. Sci Rep. 2016;6:26468.PubMedPubMedCentralCrossRef Soree P, Gupta RK, Singh K, Desiraju K, Agrawal A, Vats P, Bharadwaj A, Baburaj TP, Chaudhary P, Singh VK, et al. Raised HIF1alpha during normoxia in high altitude pulmonary edema susceptible non-mountaineers. Sci Rep. 2016;6:26468.PubMedPubMedCentralCrossRef
14.
go back to reference Gu M, Dong X, Shi L, Shi L, Lin K, Huang X, Chu J. Differences in mtDNA whole sequence between Tibetan and Han populations suggesting adaptive selection to high altitude. Gene. 2012;496(1):37–44.PubMedCrossRef Gu M, Dong X, Shi L, Shi L, Lin K, Huang X, Chu J. Differences in mtDNA whole sequence between Tibetan and Han populations suggesting adaptive selection to high altitude. Gene. 2012;496(1):37–44.PubMedCrossRef
15.
go back to reference Sharma S, Singh S, Gupta RK, Ganju L, Singh SB, Kumar B, Singh Y. Mitochondrial DNA sequencing reveals association of variants and haplogroup M33a2’3 with High altitude pulmonary edema susceptibility in Indian male lowlanders. Sci Rep. 2019;9(1):10975.PubMedPubMedCentralCrossRef Sharma S, Singh S, Gupta RK, Ganju L, Singh SB, Kumar B, Singh Y. Mitochondrial DNA sequencing reveals association of variants and haplogroup M33a2’3 with High altitude pulmonary edema susceptibility in Indian male lowlanders. Sci Rep. 2019;9(1):10975.PubMedPubMedCentralCrossRef
17.
go back to reference Kang L, Zheng HX, Zhang M, Yan S, Li L, Liu L, Liu K, Hu K, Chen F, Ma L, et al. MtDNA analysis reveals enriched pathogenic mutations in Tibetan highlanders. Sci Rep. 2016;6:31083.PubMedPubMedCentralCrossRef Kang L, Zheng HX, Zhang M, Yan S, Li L, Liu L, Liu K, Hu K, Chen F, Ma L, et al. MtDNA analysis reveals enriched pathogenic mutations in Tibetan highlanders. Sci Rep. 2016;6:31083.PubMedPubMedCentralCrossRef
19.
go back to reference St John JC, Sakkas D, Barratt CL. A role for mitochondrial DNA and sperm survival. J Androl. 2000;21(2):189–99.PubMed St John JC, Sakkas D, Barratt CL. A role for mitochondrial DNA and sperm survival. J Androl. 2000;21(2):189–99.PubMed
20.
go back to reference Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet. 1999;23(2):147.PubMedCrossRef Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet. 1999;23(2):147.PubMedCrossRef
21.
go back to reference Luo Y, Yang X, Gao Y. Mitochondrial DNA response to high altitude: a new perspective on high-altitude adaptation. Mitochondrial DNA. 2013;24(4):313–9.PubMedCrossRef Luo Y, Yang X, Gao Y. Mitochondrial DNA response to high altitude: a new perspective on high-altitude adaptation. Mitochondrial DNA. 2013;24(4):313–9.PubMedCrossRef
22.
go back to reference Luo Y, Gao W, Chen Y, Liu F, Gao Y. Rare mitochondrial DNA polymorphisms are associated with high altitude pulmonary edema (HAPE) susceptibility in Han Chinese. Wilderness Environ Med. 2012;23(2):128–32.PubMedCrossRef Luo Y, Gao W, Chen Y, Liu F, Gao Y. Rare mitochondrial DNA polymorphisms are associated with high altitude pulmonary edema (HAPE) susceptibility in Han Chinese. Wilderness Environ Med. 2012;23(2):128–32.PubMedCrossRef
23.
go back to reference Li Q, Lin K, Sun H, Liu S, Huang K, Huang X, Chu J, Yang Z. Mitochondrial haplogroup M9a1a1c1b is associated with hypoxic adaptation in the Tibetans. J Hum Genet. 2016;61(12):1021–6.PubMedCrossRef Li Q, Lin K, Sun H, Liu S, Huang K, Huang X, Chu J, Yang Z. Mitochondrial haplogroup M9a1a1c1b is associated with hypoxic adaptation in the Tibetans. J Hum Genet. 2016;61(12):1021–6.PubMedCrossRef
24.
go back to reference Leon-Velarde F, Maggiorini M, Reeves JT, Aldashev A, Asmus I, Bernardi L, Ge RL, Hackett P, Kobayashi T, Moore LG, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol. 2005;6(2):147–57.PubMedCrossRef Leon-Velarde F, Maggiorini M, Reeves JT, Aldashev A, Asmus I, Bernardi L, Ge RL, Hackett P, Kobayashi T, Moore LG, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol. 2005;6(2):147–57.PubMedCrossRef
25.
go back to reference West JB. English translation of "Nomenclature, classification, and diagnostic criteria of high altitude disease in China". High Alt Med Biol. 2010;11(2):169–72.PubMedCrossRef West JB. English translation of "Nomenclature, classification, and diagnostic criteria of high altitude disease in China". High Alt Med Biol. 2010;11(2):169–72.PubMedCrossRef
26.
go back to reference Fan L, Yao YG. MitoTool: a web server for the analysis and retrieval of human mitochondrial DNA sequence variations. Mitochondrion. 2011;11(2):351–6.PubMedCrossRef Fan L, Yao YG. MitoTool: a web server for the analysis and retrieval of human mitochondrial DNA sequence variations. Mitochondrion. 2011;11(2):351–6.PubMedCrossRef
27.
go back to reference Fan L, Yao YG. An update to MitoTool: using a new scoring system for faster mtDNA haplogroup determination. Mitochondrion. 2013;13(4):360–3.PubMedCrossRef Fan L, Yao YG. An update to MitoTool: using a new scoring system for faster mtDNA haplogroup determination. Mitochondrion. 2013;13(4):360–3.PubMedCrossRef
28.
go back to reference van Oven M, Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 2009;30(2):E386-394.PubMedCrossRef van Oven M, Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 2009;30(2):E386-394.PubMedCrossRef
29.
go back to reference Strapazzon G, Vezzaro R, Hofer G, Dal Cappello T, Procter E, Balkenhol K, Platzgummer S, Brugger H. Factors associated with B-lines after exposure to hypobaric hypoxia. Eur Heart J Cardiovasc Imaging. 2015;16(11):1241–6.PubMedCrossRef Strapazzon G, Vezzaro R, Hofer G, Dal Cappello T, Procter E, Balkenhol K, Platzgummer S, Brugger H. Factors associated with B-lines after exposure to hypobaric hypoxia. Eur Heart J Cardiovasc Imaging. 2015;16(11):1241–6.PubMedCrossRef
30.
go back to reference Richalet JP, Larmignat P, Poitrine E, Letournel M, Canoui-Poitrine F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med. 2012;185(2):192–8.PubMedCrossRef Richalet JP, Larmignat P, Poitrine E, Letournel M, Canoui-Poitrine F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med. 2012;185(2):192–8.PubMedCrossRef
31.
go back to reference Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, Falda A, Pizzi S, Parenti A, et al. Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am J Clin Pathol. 2006;126(4):593–601.PubMedCrossRef Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, Falda A, Pizzi S, Parenti A, et al. Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am J Clin Pathol. 2006;126(4):593–601.PubMedCrossRef
32.
go back to reference Sequeira A, Martin MV, Rollins B, Moon EA, Bunney WE, Macciardi F, Lupoli S, Smith EN, Kelsoe J, Magnan CN, et al. Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Genet. 2012;3:103.PubMedPubMedCentralCrossRef Sequeira A, Martin MV, Rollins B, Moon EA, Bunney WE, Macciardi F, Lupoli S, Smith EN, Kelsoe J, Magnan CN, et al. Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Genet. 2012;3:103.PubMedPubMedCentralCrossRef
34.
go back to reference Luo YJ, Gao WX, Li SZ, Huang XW, Chen Y, Liu FY, Huang QY, Gao YQ. Mitochondrial haplogroup D4 confers resistance and haplogroup B is a genetic risk factor for high-altitude pulmonary edema among Han Chinese. Genet Mol Res. 2012;11(4):3658–67.PubMedCrossRef Luo YJ, Gao WX, Li SZ, Huang XW, Chen Y, Liu FY, Huang QY, Gao YQ. Mitochondrial haplogroup D4 confers resistance and haplogroup B is a genetic risk factor for high-altitude pulmonary edema among Han Chinese. Genet Mol Res. 2012;11(4):3658–67.PubMedCrossRef
35.
go back to reference Soares P, Ermini L, Thomson N, Mormina M, Rito T, Rohl A, Salas A, Oppenheimer S, Macaulay V, Richards MB. Correcting for purifying selection: an improved human mitochondrial molecular clock. Am J Hum Genet. 2009;84(6):740–59.PubMedPubMedCentralCrossRef Soares P, Ermini L, Thomson N, Mormina M, Rito T, Rohl A, Salas A, Oppenheimer S, Macaulay V, Richards MB. Correcting for purifying selection: an improved human mitochondrial molecular clock. Am J Hum Genet. 2009;84(6):740–59.PubMedPubMedCentralCrossRef
36.
go back to reference Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 2007;67(10):4687–94.PubMedCrossRef Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 2007;67(10):4687–94.PubMedCrossRef
37.
go back to reference Peng Z, Xie C, Wan Q, Zhang L, Li W, Wu S. Sequence variations of mitochondrial DNA D-loop region are associated with familial nasopharyngeal carcinoma. Mitochondrion. 2011;11(2):327–33.PubMedCrossRef Peng Z, Xie C, Wan Q, Zhang L, Li W, Wu S. Sequence variations of mitochondrial DNA D-loop region are associated with familial nasopharyngeal carcinoma. Mitochondrion. 2011;11(2):327–33.PubMedCrossRef
38.
go back to reference Liao WQ, Pang Y, Yu CA, Wen JY, Zhang YG, Li XH. Novel mutations of mitochondrial DNA associated with type 2 diabetes in Chinese Han population. Tohoku J Exp Med. 2008;215(4):377–84.PubMedCrossRef Liao WQ, Pang Y, Yu CA, Wen JY, Zhang YG, Li XH. Novel mutations of mitochondrial DNA associated with type 2 diabetes in Chinese Han population. Tohoku J Exp Med. 2008;215(4):377–84.PubMedCrossRef
39.
go back to reference Murakami H, Ota A, Simojo H, Okada M, Ajisaka R, Kuno S. Polymorphisms in control region of mtDNA relates to individual differences in endurance capacity or trainability. Jpn J Physiol. 2002;52(3):247–56.PubMedCrossRef Murakami H, Ota A, Simojo H, Okada M, Ajisaka R, Kuno S. Polymorphisms in control region of mtDNA relates to individual differences in endurance capacity or trainability. Jpn J Physiol. 2002;52(3):247–56.PubMedCrossRef
40.
go back to reference Zaki EA, Freilinger T, Klopstock T, Baldwin EE, Heisner KR, Adams K, Dichgans M, Wagler S, Boles RG. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia. 2009;29(7):719–28.PubMedCrossRef Zaki EA, Freilinger T, Klopstock T, Baldwin EE, Heisner KR, Adams K, Dichgans M, Wagler S, Boles RG. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia. 2009;29(7):719–28.PubMedCrossRef
41.
go back to reference Hjelm BE, Rollins B, Mamdani F, Lauterborn JC, Kirov G, Lynch G, Gall CM, Sequeira A, Vawter MP. Evidence of mitochondrial dysfunction within the complex genetic etiology of schizophrenia. Mol Neuropsychiatry. 2015;1(4):201–19.PubMedPubMedCentral Hjelm BE, Rollins B, Mamdani F, Lauterborn JC, Kirov G, Lynch G, Gall CM, Sequeira A, Vawter MP. Evidence of mitochondrial dysfunction within the complex genetic etiology of schizophrenia. Mol Neuropsychiatry. 2015;1(4):201–19.PubMedPubMedCentral
42.
go back to reference Maassen JA, Janssen GM, t Hart LM. Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med. 2005;37(3):213–21.PubMedCrossRef Maassen JA, Janssen GM, t Hart LM. Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med. 2005;37(3):213–21.PubMedCrossRef
43.
go back to reference Simmons RA, Suponitsky-Kroyter I, Selak MA. Progressive accumulation of mitochondrial DNA mutations and decline in mitochondrial function lead to beta-cell failure. J Biol Chem. 2005;280(31):28785–91.PubMedCrossRef Simmons RA, Suponitsky-Kroyter I, Selak MA. Progressive accumulation of mitochondrial DNA mutations and decline in mitochondrial function lead to beta-cell failure. J Biol Chem. 2005;280(31):28785–91.PubMedCrossRef
44.
45.
go back to reference Underhill PA, Kivisild T. Use of y chromosome and mitochondrial DNA population structure in tracing human migrations. Annu Rev Genet. 2007;41:539–64.PubMedCrossRef Underhill PA, Kivisild T. Use of y chromosome and mitochondrial DNA population structure in tracing human migrations. Annu Rev Genet. 2007;41:539–64.PubMedCrossRef
46.
go back to reference Luo Y, Gao W, Liu F, Gao Y. Mitochondrial nt3010G-nt3970C haplotype is implicated in high-altitude adaptation of Tibetans. Mitochondrial DNA. 2011;22(5–6):181–90.PubMedCrossRef Luo Y, Gao W, Liu F, Gao Y. Mitochondrial nt3010G-nt3970C haplotype is implicated in high-altitude adaptation of Tibetans. Mitochondrial DNA. 2011;22(5–6):181–90.PubMedCrossRef
47.
go back to reference Li FX, Ji FY, Zheng SZ, Yao W, Xiao ZL, Qian GS. MtDNA haplogroups M7 and B in southwestern Han Chinese at risk for acute mountain sickness. Mitochondrion. 2011;11(4):553–8.PubMedPubMedCentralCrossRef Li FX, Ji FY, Zheng SZ, Yao W, Xiao ZL, Qian GS. MtDNA haplogroups M7 and B in southwestern Han Chinese at risk for acute mountain sickness. Mitochondrion. 2011;11(4):553–8.PubMedPubMedCentralCrossRef
Metadata
Title
Association of variants m.T16172C and m.T16519C in whole mtDNA sequences with high altitude pulmonary edema in Han Chinese lowlanders
Authors
Yan Wang
Xuewen Huang
Fujun Peng
Huiling Han
Yanan Gu
Xin Liu
Zhichun Feng
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Pulmonary Edema
Published in
BMC Pulmonary Medicine / Issue 1/2022
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01791-1

Other articles of this Issue 1/2022

BMC Pulmonary Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.